Crossmark

Vitamin D supplementation and COVID-19 disease: safety but unproven efficacy—reply to Dr Helga Rhein

Published Online: 2021-08-18

Published Print: 2021-09

Authors

Harvey, Nicholas C. https://orcid.org/0000-0002-8194-2512
Cooper, Cyrus

Raisi-Estabragh, Zahra
License Information

Text and Data Mining valid from 2021-08-18

Version of Record valid from 2021-08-18
More Information

Article History

Received: 11 July 2021

Accepted: 29 July 2021

First Online: 18 August 2021

Declarations

:

: NCH reports personal fees, consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Consilient Healthcare, Kyowa Kirin and Internis Pharma, outside the submitted work. CC reports personal fees, consultancy, lecture fees and honoraria from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB. ZRE reports no conflicts of interest.

: There was no direct involvement of patients or participants in this letter.

: Ethics review and informed consent are not applicable.

Free to read: This content has been made available to all.

Document is current